| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/15/2003 | EP1351671A1 Triphenylmethane kinesin inhibitors |
| 10/15/2003 | EP1351670A1 Methods for treating neuropsychiatric disorders with nmda receptor antagonists |
| 10/15/2003 | EP1351669A1 Clear propofol compositions |
| 10/15/2003 | EP1351668A1 Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
| 10/15/2003 | EP1351667A1 Pharmaceutical composition containing citalopram |
| 10/15/2003 | EP1351666A1 A method for the preparation of nanoparticles |
| 10/15/2003 | EP1351663A1 Cosmetic and/or pharmaceutical preparations |
| 10/15/2003 | EP1351662A1 Cosmetic and/or pharmaceutical preparations |
| 10/15/2003 | EP1351647A1 Compositions and methods for treating hyperpigmentation |
| 10/15/2003 | EP1351573A1 Methods for modulating tumor growth and metastasis |
| 10/15/2003 | EP1268471B1 N-heterocyclic derivatives as nos inhibitors |
| 10/15/2003 | EP1265873B1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 10/15/2003 | EP1259508B1 Novel biarylcarboxamides |
| 10/15/2003 | EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 10/15/2003 | EP1244427B1 Pharmaceutical compositions for oral administration |
| 10/15/2003 | EP1233758B1 Sodium valproate granulate with reduced hygroscopicity |
| 10/15/2003 | EP1231909B1 Use of ubiquinone q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies |
| 10/15/2003 | EP1228041B1 Indole derivatives and their use as 5ht2a ligands |
| 10/15/2003 | EP1212316B1 Benzopyrans and benzothiopyrans as rar selective retinoid agonists |
| 10/15/2003 | EP1206457B1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 10/15/2003 | EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease |
| 10/15/2003 | EP1173181B1 Composition comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction |
| 10/15/2003 | EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 10/15/2003 | EP1094796B1 Topical plaster with non-steroidal antirheumatic agents with an acid group |
| 10/15/2003 | EP1071409B1 Use of organophosphoric compounds for the therapeutic and preventative treatment of infections |
| 10/15/2003 | EP1054890B1 Oligodeoxyribonucleotides comprising o6-benzylguanine and their use |
| 10/15/2003 | EP1007096B1 Arginine silicate inositol complex and use thereof |
| 10/15/2003 | EP1005332B1 Pharmaceutical composition for reducing production of mcp-1 protein |
| 10/15/2003 | EP0998464B1 Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them |
| 10/15/2003 | EP0986564B1 6-SUBSTITUTED 1,2,4A,5A,8A,8A HEXAHYDRO- AND 1,2,3,4,4A,5A,8A,8B-OCTAHYDRO-6H-PYRROLO[3',4':4,5]FURO[3,2-b]PYRID-8(7H)-ONE DERIVATIVES AND THEIR USE IN COMBATTING ENDOPARASITES |
| 10/15/2003 | EP0977757B1 9,10-diazatricyclo 4.2.1.1?2,5 ]decane and 9,10-diazatricyclo 3.3.1.1?2,6 ]decane derivatives having analgesic activity |
| 10/15/2003 | EP0975370B1 Composition and method for enhancing transport across biological membranes |
| 10/15/2003 | EP0972768B1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same |
| 10/15/2003 | EP0956019B1 Novel therapeutic application of a thienycyclohexylamine derivative |
| 10/15/2003 | EP0954296B1 Use of bronopol for the treatment of diseases in fish |
| 10/15/2003 | EP0950047B1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 10/15/2003 | EP0916651B1 Phenylalkylcarboxylic acid derivatives |
| 10/15/2003 | EP0910383B1 The use of growth factor modulating compounds |
| 10/15/2003 | EP0910367B1 Use of vitamin e acetate |
| 10/15/2003 | EP0888351B1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
| 10/15/2003 | EP0876140B1 Improved kontrast agent solutions for intravenous administration |
| 10/15/2003 | EP0874558B1 Liquid oral compositions comprising a calcium compound and an acidulant |
| 10/15/2003 | EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use |
| 10/15/2003 | EP0855391B1 Novel isoquinoline derivatives |
| 10/15/2003 | EP0831769B1 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 10/15/2003 | EP0797575B1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
| 10/15/2003 | EP0769502B1 Process for producing desulfated polysaccharide and desulfated heparin |
| 10/15/2003 | EP0766674B1 New hiv protease inhibitors |
| 10/15/2003 | EP0763032B1 Palladium catalyzed ring closure of triazolyl tryptamine |
| 10/15/2003 | EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives |
| 10/15/2003 | CN1449493A Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 10/15/2003 | CN1449448A 干细胞分化 Stem cell differentiation |
| 10/15/2003 | CN1449445A Ev-vegf nucleic acids and polypeptides and methods of use |
| 10/15/2003 | CN1449443A 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 10/15/2003 | CN1449440A Masp-2, a complement-fixing enzyme, and uses for it |
| 10/15/2003 | CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 10/15/2003 | CN1449399A Polycyclic xanthones as antibiotics |
| 10/15/2003 | CN1449398A 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
| 10/15/2003 | CN1449397A 2,5-dihydro-pyrazolo(3,4-d)pyrimidin-4-ones with an anticonvulsive action and methods for producing the same |
| 10/15/2003 | CN1449396A Carbamates derived from arylalkylamines |
| 10/15/2003 | CN1449395A Process for preparing azacycloalkanoyl aminothiazoles |
| 10/15/2003 | CN1449391A N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide |
| 10/15/2003 | CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 10/15/2003 | CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 10/15/2003 | CN1449384A Novel ester or amide derivatives |
| 10/15/2003 | CN1449382A Polyarylcarboxamides useful as lipid lowering agents |
| 10/15/2003 | CN1449381A New compounds having activity of lowing blood fat and cholesterol, their preparation method and pharmaceutical compositions containing them |
| 10/15/2003 | CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 10/15/2003 | CN1449377A Inhibitors of alpha4 mediated cell adhesion |
| 10/15/2003 | CN1449375A Use of pamoic acid or one of derivatives or analogs thereof for preparing a medicament used for treating diseases |
| 10/15/2003 | CN1449290A Combinations of dalfopristine/quinupristine with cefpirome |
| 10/15/2003 | CN1449289A Oct制剂 Oct preparations |
| 10/15/2003 | CN1449288A Pharmaceutical formulation of salmeterol and fluticasone propionate |
| 10/15/2003 | CN1449287A Fused pyrrolocarbazoles against inflammation |
| 10/15/2003 | CN1449286A Carvedilol |
| 10/15/2003 | CN1449285A Use of il-8 receptor antagonists in the treatment of virus infections |
| 10/15/2003 | CN1449284A 维生素c组合物 Vitamin c composition |
| 10/15/2003 | CN1449283A Compositions for ameliorating attention-deficient/hyperactivity disorder |
| 10/15/2003 | CN1449282A Treatment of burns |
| 10/15/2003 | CN1449281A Medicaments for treating colics |
| 10/15/2003 | CN1449280A Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 10/15/2003 | CN1449279A Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 10/15/2003 | CN1449274A Hair growers |
| 10/15/2003 | CN1449273A Antimicotic nail varnish composition |
| 10/15/2003 | CN1449271A Method and manufacture of a wound dressing for covering an open wound |
| 10/15/2003 | CN1449270A Topical compositions containing prostaglandin e1 |
| 10/15/2003 | CN1449024A Erase scheme for non-volatile memory |
| 10/15/2003 | CN1448505A Method for production of phytolaccatoxin medicinal active substance |
| 10/15/2003 | CN1448420A Hydrophilic polymer and tanshinones medicine conjugation agent and medicine composition containing same |
| 10/15/2003 | CN1448409A Chi lucid ganoderma polysaccharide and prep. and use thereof |
| 10/15/2003 | CN1448397A Process of extracting total flavone glycoside from mistletoe and medicine composition thereof |
| 10/15/2003 | CN1448184A Injectable pharmaceutical composition containing non-steroid antiphlogistic medicament and method for making same |
| 10/15/2003 | CN1448153A Ointment for treating dermatopathy and preparing process thereof |
| 10/15/2003 | CN1448142A Compositions comprising cytosine derivatives for the treatment of cancer |
| 10/15/2003 | CN1448141A Medine using cornin as main composition for curing chronic nephritis and productive technology thereof |
| 10/15/2003 | CN1448140A Sea urchin containing preparation and its preparing method |
| 10/15/2003 | CN1448139A Antipruritic liniment |
| 10/15/2003 | CN1448138A Artesunate and dihydroarteannuin medicine preparation for proofing formation of blood vessel and use thereof |
| 10/15/2003 | CN1448137A Gatifloxacin external and ophthalmic gel preparation |
| 10/15/2003 | CN1448136A Furbenicillin antiseptic composite medicine |